FDA rejects Eagle Pharmaceuticals' heat stroke treatment

(Reuters) - Eagle Pharmaceuticals Inc said on Tuesday the U.S. Food and Drug Administration declined to approve its drug Ryanodex to treat heat stroke and requested an additional clinical trial.